ClinicalTrials.Veeva

Menu

Regional Block of the Nose for Hypotensive Anaesthesia in Septo-rhinoplasty

A

Ain Shams University

Status

Unknown

Conditions

Hypotensive Anesthesia

Treatments

Other: General anesthesia with fentanyl boluses
Procedure: Regional block

Study type

Interventional

Funder types

Other

Identifiers

NCT03774693
FMASU R66/2018

Details and patient eligibility

About

Septorhinoplasty is a cosmetic surgery that many people are choosing to undergo. It can be done under general anesthesia, twilight anesthesia or regional anesthesia. Controlled hypotensive anesthesia is required to minimize bruising, swelling, and bleeding that reduces visibility in the operative field and hence satisfactory surgical outcome.

The goal of our study to prove that regional block of the nose provides efficient hypotensive anesthesia

Enrollment

60 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • American Society of Anesthesiologists (ASA) physical status I-II
  • Scheduled for elective septo-rhinoplasty surgery

Exclusion criteria

  • Patients with hypertension or coronary artery disease,
  • Patients with renal, hepatic or cerebral insufficiency,
  • Patients with coagulopathy or receiving drugs influencing blood coagulation,
  • Patients with known sensitivity to any of the study drug

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

GS [General anesthesia]
Active Comparator group
Description:
Patients will receive general anesthesia with Fentanyl boluses of 0.5 mcg.Kg-1 given to maintain MAP between 55-65 mmHg with a maximum dose of 3 mcg.Kg-1.
Treatment:
Other: General anesthesia with fentanyl boluses
GR [General anesthesia + regional block]
Active Comparator group
Description:
Patients will receive general anesthesia with Fentanyl boluses of 0.5 mcg.Kg-1 given to maintain MAP between 55-65 mmHg with a maximum dose of 3 mcg.Kg-1. Also patients will receive trans-oral bilateral sphenopalatine ganglion block and trans-oral bilateral infraorbital nerve block. Fentanyl boluses of 0.5 mcg.Kg-1 will be given when needed to maintain MAP between 55-65 mmHg with a maximum dose of 3 mcg.Kg-1.
Treatment:
Procedure: Regional block
Other: General anesthesia with fentanyl boluses

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems